Financing of Merida Biosciences was backed by Bain Capital Life Sciences, BVF Partners and Third Rock Ventures, with ...

Davidi Vortman, CEO, UltraSight, discusses how AI-powered heart scan technology can help high-risk cardiovascular disease ...

PharmaLogic states that the acquisition of Agilera Pharma AS will place the company in a unique global role in ...

As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not ...

LaShell Robinson, head of global feasibility and trial equity at Takeda, discusses how Takeda will ensure that diversity and inclusion remain a priority in its clinical trials moving forward.

CVS Health announced that Brian Newman will serve as executive vice president and chief financial officer (CFO) starting on April 21. 1 The company’s previous CFO, Tom Cowhey, will move to a new ...

The survey also suggests that Medicaid is broadly popular amongst all Americans, regardless of political affiliation.

Hyfe’s CEO Tamsin Chislett spoke with Pharmaceutical Executive about this new technology, along with how digital therapeutics ...

Brimochol PF, a combination of brimonidine and carbachol, was found to enhance depth of focus and visual acuity in clinical ...

LaShell Robinson, head of global feasibility and trial equity at Takeda, identifies some of the key barriers in achieving representative clinical trials for psoriasis, and how they are overcoming them ...

Amy Hessels, Bayer‘s vice president of marketing, talks about how to engage younger demographics and how the Your Decision campaign contributes to broader conversations about women's reproductive ...

We’re going to tariff our pharmaceuticals, and once we do that, they are going to come rushing back into our country," ...